Healthcare Services

Gene Panel Market Projected To Surpass $4.95 Billion By 2030 At 14.9% CAGR

May 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Size Of The Gene Panel Market Progress Through 2030?

The gene panel market size has experienced significant expansion recently. This market is projected to expand from $2.47 billion in 2025 to $2.85 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 15.3%. Historically, factors such as advancements in next-generation sequencing, declining sequencing expenses, increased adoption of clinical genetics, the proliferation of diagnostic laboratories, and robust oncology biomarker research have contributed to this growth.

The gene panel market size is projected to experience substantial expansion in the coming years, reaching $4.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.9%. Factors contributing to this anticipated growth include the rise of personalized medicine, the broadening scope of hereditary disease testing, an increasing need for precision diagnostics, the incorporation of AI into genomic analysis, and more widespread clinical acceptance. Key trends anticipated during the forecast period involve the increasing uptake of multi-gene diagnostic panels, their expanded application in cancer risk assessment, the growth of customized gene panel testing, a surging requirement for pharmacogenomic insights, and the incorporation of gene panels into clinical decision-making processes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21190&type=smp

Which Core Factors Are Supporting The Expansion Of The Gene Panel Market?

The escalating incidence of cancer is anticipated to propel the growth of the gene panel market in the foreseeable future. Cancer is defined as a spectrum of illnesses distinguished by the unregulated proliferation and spread of abnormal cells, which possess the capability to invade and damage surrounding tissues and organs. The rising number of cancer cases can be attributed to factors such as an aging populace, shifts in lifestyle, environmental exposures, and advancements in detection and diagnostic methods. Gene panels aid in the fight against cancer by enabling comprehensive genetic analysis to pinpoint mutations and alterations in specific genes, thereby guiding personalized treatment plans and improving patient outcomes. For instance, in January 2023, according to the PubMed, a US-based free search engine for biomedical and life sciences literature maintained by the United States National Library of Medicine, it was reported that in 2023, an estimated 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States. Thus, the increasing prevalence of cancer is a significant driver for the expansion of the gene panel market.

How Does Segment Analysis Break Down The Gene Panel Market Structure?

The gene panel market covered in this report is segmented –

1) By Product And Services: Test Kits, Testing Services

2) By Technology: Amplicon-Based, Hybridization-Based, Other Technologies

3) By Design: Predesigned Gene Panel, Customized Gene Panel

4) By Application: Cancer Risk Assessment, Diagnosis Of Congenital Diseases, Pharmacogenetics, Other Applications

5) By End-User: Research Institutes, Hospital, Diagnosis Centers, Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Test Kits: Predesigned Gene Panels, Customized Gene Panels

2) By Testing Services: Cancer Risk Assessment Panels, Pharmacogenetic Testing Panels, Neurological Disorder Panels, Cardiovascular Disease Panels, Rare Disease Panels

What Trends Are Influencing The Gene Panel Market Outlook?

Leading companies in the gene panel market are concentrating on developing innovative technologies, such as oncology panels, to boost the accuracy, efficiency, and comprehensiveness of cancer diagnostics and personalized treatment strategies. Oncology panels are specialized gene panels that scrutinize multiple genes linked to cancer to detect genetic mutations and alterations, thereby supporting cancer diagnosis, prognosis, and treatment. For example, in May 2023, Vizgen Inc., a US-based biotechnology company, introduced the MERFISH PanCancer Pathways Panel, presenting a customizable choice for scientists entering the domain of spatial genomics. These predesigned panels are specifically configured for various research uses, including cancer studies, and are optimized for improved error robustness, delivering reliable and reproducible results. By incorporating spatial data with gene expression information, the panels offer more profound insights into tumor microenvironments and cellular interactions, facilitating more focused and individualized cancer research and therapeutic advancement. This launch signifies a notable progression in spatial biology, empowering researchers to investigate complex biological systems with a level of detail previously unachievable.

Who Are The Companies Shaping The Gene Panel Market Landscape?

Major companies operating in the gene panel market are F. Hoffmann-La Roche, Thermo Fisher Scientific, Quest Diagnostics, Eurofins Scientific, Agilent Technologies, Illumina, Qiagen, Myriad Genetics, Guardant Health, Invitae, Integrated DNA Technologies, Bio-Rad, Novogene, Fulgent Genetics, MedGenome, Centogene, Blueprint Genetics, BIONEER, BGI Group.

Access The Complete Gene Panel Market Report:

https://www.thebusinessresearchcompany.com/report/gene-panel-global-market-report

Which Region Leads The Gene Panel Market By Size?

North America was the largest region in the gene panel market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene panel market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Gene Panel Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=21190&type=smp

Browse Through More Reports Similar to the Global Gene Panel Market 2026, By The Business Research Company

Crispr Gene Editing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report

Genome Editing Or Genome Engineering Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

Genes Therapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795